Drug Search Results

Diquafosol

Alternative Names: diquafosol, ins365, tjo-083, tjo083
Latest Update: 2024-08-19
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: P2Y Agonist

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Ocular,Topical,Ophthalmic

FDA Designation: None *

Approval Status: Not Approved

Approved Indications: None

Known Adverse Events: None

Company: Merck
Company Location: KENILWORTH NJ 07033
Company CEO: Robert M. Davis
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Diquafosol

Countries in Clinic: Indonesia, Korea

Active Clinical Trial Count: 2

Highest Development Phases

Phase 3: Dry Eye Disease|Dry Eye Syndromes|Keratoconjunctivitis Sicca

Phase 2: Cataract

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
TJO-083-A03	P3	Recruiting	Keratoconjunctivitis Sicca\|Dry Eye Disease\|Dry Eye Syndromes	2024-12-31	38%
NCT06146881	P2	Recruiting	Keratoconjunctivitis Sicca\|Dry Eye Disease\|Dry Eye Syndromes\|Cataract	2023-12-15

Recent News Events

Date	Type	Title
05/06/2024	PubMed	Effects of a Long-Acting Diquafosol Ophthalmic Solution on the Ocular Surface, Tolerability, and Usability in Dry Eye Disease.
04/25/2024	PubMed	Effect of Long-Acting Diquafosol Sodium on Astigmatism Measurement Repeatability in Preoperative Cataract Cases with Dry Eyes: A Multicenter Prospective Study.
01/25/2024	PubMed	Validation of an Ion-Pair Reverse Phase High-Performance Liquid Chromatography Method for the Detection of Major Components and Related Substances in Diquafosol Sodium Eye Drops.
09/09/2023	News Article	Fresh Compressed Yeast Market 2023 Technology Advancements and Research- AngelYeast, Lesaffre Yeast, Associated British Foods
04/27/2023	News Article	Yuyu Pharma, Dry Eye Pipeline Mechanism of Action and Pre-clinical Results Published
02/10/2023	News Article	Dry Eye Syndrome Treatment Market to Surpass US$ 24,449.7 Million by 2030, Says Coherent Market Insights (CMI)

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions